ERIC CARTER: Open Payments
NPI 1114680451 · ERWIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 42 payments from 12 companies in 2025. Trend: 2023 $1,054 · 2024 $1,109 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $357 |
| Novo Nordisk Inc | 10 | $251 |
| Gilead Sciences, Inc. | 2 | $151 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| KYOWA KIRIN, INC. | 1 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| ABBVIE INC. | 3 | $59 |
| Exact Sciences Corporation | 3 | $55 |
| Lilly USA, LLC | 2 | $41 |
| Viatris Specialty LLC | 1 | $26 |
Products named: AIRSUPRA, Auvelity, Ozempic, Epclusa, CAPLYTA, BREZTRI, Wegovy, VRAYLAR.
Industry payments across TN — which companies pay providers there.
